Liu Y, Izem L, Morton R. Identification of a hormone response element that mediates suppression of APOF by LXR and PPARα agonists. Biochim Biophys Acta Mol Cell Biol Lipids. 2020;1865:158583 pubmed publisher

Fujimori K, Iguchi Y, Yamashita Y, Gohda K, Teno N. Synthesis of Novel Farnesoid X Receptor Agonists and Validation of Their Efficacy in Activating Differentiation of Mouse Bone Marrow-Derived Mesenchymal Stem Cells into Osteoblasts. Molecules. 2019;24: pubmed publisher

Huan Y, Pan X, Peng J, Jia C, Sun S, Bai G, et al. A novel specific peroxisome proliferator-activated receptor γ (PPARγ) modulator YR4-42 ameliorates hyperglycaemia and dyslipidaemia and hepatic steatosis in diet-induced obese mice. Diabetes Obes Metab. 2019;21:2553-2563 pubmed publisher

Guo S, Som A, Arai K, Lo E. Effects of angiotensin-II on brain endothelial cell permeability via PPARalpha regulation of para- and trans-cellular pathways. Brain Res. 2019;1722:146353 pubmed publisher

Nogueira Recalde U, Lorenzo Gómez I, Blanco F, Loza M, Grassi D, Shirinsky V, et al. Fibrates as drugs with senolytic and autophagic activity for osteoarthritis therapy. EBioMedicine. 2019;45:588-605 pubmed publisher

Hwang J, So Y, Bae G, Kim S, Kim Y. Protein arginine methyltransferase 6 suppresses adipogenic differentiation by repressing peroxisome proliferator‑activated receptor γ activity. Int J Mol Med. 2019;43:2462-2470 pubmed publisher

Luckert C, Braeuning A, Lampen A, Hessel Pras S. PXR: Structure-specific activation by hepatotoxic pyrrolizidine alkaloids. Chem Biol Interact. 2018;288:38-48 pubmed publisher

Ord T, Ord D, Ord T. TRIB3 limits FGF21 induction during in vitro and in vivo nutrient deficiencies by inhibiting C/EBP-ATF response elements in the Fgf21 promoter. Biochim Biophys Acta Gene Regul Mech. 2018;1861:271-281 pubmed publisher

Valanejad L, Ghareeb M, Shiffka S, Nadolny C, Chen Y, Guo L, et al. Dysregulation of Δ4-3-oxosteroid 5β-reductase in diabetic patients: Implications and mechanisms. Mol Cell Endocrinol. 2018;470:127-141 pubmed publisher

Cheng Y, Wei Z, Xie S, Peng Y, Yan Y, Qin D, et al. Alleviation of Toxicity Caused by Overactivation of Ppar? through Ppar?-Inducible miR-181a2. Mol Ther Nucleic Acids. 2017;9:195-206 pubmed publisher

Wu J, Wang J, Liu T, Zhou Y, Qiu C, Shen D, et al. PPAR-? acutely inhibits functional activity of ASICs in rat dorsal root ganglion neurons. Oncotarget. 2017;8:93051-93062 pubmed publisher

Vergori L, Lauret E, Soleti R, Andriantsitohaina R, Carmen Martínez M. Microparticles Carrying Peroxisome Proliferator-Activated Receptor Alpha Restore the Reduced Differentiation and Functionality of Bone Marrow-Derived Cells Induced by High-Fat Diet. Stem Cells Transl Med. 2017;: pubmed publisher

Kim Y, Hwang S, Jia Y, Seo W, Lee S. Barley sprout extracts reduce hepatic lipid accumulation in ethanol-fed mice by activating hepatic AMP-activated protein kinase. Food Res Int. 2017;101:209-217 pubmed publisher

Petta I, Bougarne N, Vandewalle J, Dejager L, Vandevyver S, Ballegeer M, et al. Glucocorticoid Receptor-mediated transactivation is hampered by Striatin-3, a novel interaction partner of the receptor. Sci Rep. 2017;7:8941 pubmed publisher

Zhang J, Wang X, Liu X, Huan Y, Yang M, Shen Z, et al. Design, sythesis and evaluation of a series of 3- or 4-alkoxy substituted phenoxy derivatives as PPARs agonists. Oncotarget. 2017;8:20766-20783 pubmed publisher

van der Krieken S, Popeijus H, Konings M, Dullens S, Mensink R, Plat J. C/EBP-β Is Differentially Affected by PPARα Agonists Fenofibric Acid and GW7647, But Does Not Change Apolipoprotein A-I Production During ER-Stress and Inflammation. J Cell Biochem. 2017;118:754-763 pubmed publisher

He P, Li Y, Ding X, Sun Q, Huang Y, Gu H, et al. Expression of 15-Hydroxyprostaglandin Dehydrogenase in Human Chorion Is Associated with Peroxisome Proliferator-Activated Receptor Isoform Expression in Term Labor. Am J Pathol. 2015;185:1981-90 pubmed publisher

Martinez A, Morgese M, Pisanu A, Macheda T, Paquette M, Seillier A, et al. Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats. Neurobiol Dis. 2015;74:295-304 pubmed publisher

Langhi C, Baldán Ã. CIDEC/FSP27 is regulated by peroxisome proliferator-activated receptor alpha and plays a critical role in fasting- and diet-induced hepatosteatosis. Hepatology. 2015;61:1227-38 pubmed publisher

Tanner L, Chng C, Guan X, Lei Z, Rozen S, Wenk M. Lipidomics identifies a requirement for peroxisomal function during influenza virus replication. J Lipid Res. 2014;55:1357-65 pubmed publisher

Cyphert H, Alonge K, Ippagunta S, Hillgartner F. Glucagon stimulates hepatic FGF21 secretion through a PKA- and EPAC-dependent posttranscriptional mechanism. PLoS ONE. 2014;9:e94996 pubmed publisher

Masoodi M, Lee E, Eiden M, Bahlo A, Shi Y, Ceddia R, et al. A role for oleoylethanolamide in chronic lymphocytic leukemia. Leukemia. 2014;28:1381-7 pubmed publisher

Gregoire F, Zhang F, Clarke H, Gustafson T, SEARS D, Favelyukis S, et al. MBX-102/JNJ39659100, a novel peroxisome proliferator-activated receptor-ligand with weak transactivation activity retains antidiabetic properties in the absence of weight gain and edema. Mol Endocrinol. 2009;23:975-88 pubmed publisher

Ramanan S, Kooshki M, Zhao W, Hsu F, Robbins M. PPARalpha ligands inhibit radiation-induced microglial inflammatory responses by negatively regulating NF-kappaB and AP-1 pathways. Free Radic Biol Med. 2008;45:1695-704 pubmed publisher

Mazzucotelli A, Viguerie N, Tiraby C, Annicotte J, Mairal A, Klimcakova E, et al. The transcriptional coactivator peroxisome proliferator activated receptor (PPAR)gamma coactivator-1 alpha and the nuclear receptor PPAR alpha control the expression of glycerol kinase and metabolism genes independently of PPAR gamma activation in hu. Diabetes. 2007;56:2467-75 pubmed